Quick Answer
Rein Therapeutics, Inc. reported Shares Outstanding of 27.55 million shares for fiscal year 2025.
Rein Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 27.55M | +27.2% |
| 2024 | 21.67M | +343.5% |
| 2023 | 4.89M | +7.6% |
| 2022 | 4.54M | +0.3% |
| 2021 | 4.53M | -89.7% |
| 2020 | 43.80M | +57.5% |
| 2019 | 27.81M | +88.6% |
| 2018 | 14.75M | +0.2% |
| 2017 | 14.72M | +3305.0% |
| 2016 | 432,413 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 25.14M | +16.0% | +9.1% |
| June 30, 2025 | 23.05M | +6.6% | +4.7% |
| March 31, 2025 | 22.01M | +30.7% | +1.6% |
| December 31, 2024 | 21.67M | +343.5% | +0.0% |
| September 30, 2024 | 21.67M | +377.1% | +0.2% |
| June 30, 2024 | 21.63M | +376.2% | +28.4% |
| March 31, 2024 | 16.84M | +270.9% | +244.7% |
| December 31, 2023 | 4.89M | +7.6% | +7.6% |
- Rein Therapeutics, Inc. showed an increase of +27.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, Rein Therapeutics, Inc.’s shares outstanding has grown by 6271.3% (from 432.4 thousand shares to 27.55 million shares).
- The most recent figure is from Rein Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: